ImmuCell Corporation (ICCC)
NASDAQ: ICCC · Real-Time Price · USD
9.79
-0.10 (-1.01%)
Jun 26, 2026, 4:00 PM EDT - Market closed
ImmuCell Employees
ImmuCell had 73 employees as of December 31, 2025. The number of employees decreased by 2 or -2.67% compared to the previous year.
Employees
73
Change (1Y)
-2
Growth (1Y)
-2.67%
Revenue / Employee
$410,059
Profits / Employee
-$7,471
Market Cap
88.57M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Inovio Pharmaceuticals | 112 |
| PolyPid | 75 |
| Rani Therapeutics Holdings | 71 |
| Biomea Fusion | 40 |
| NeurAxis | 24 |
| Atara Biotherapeutics | 13 |
| ProMIS Neurosciences | 11 |
| Rein Therapeutics | 10 |
ICCC News
- 15 days ago - ImmuCell Slides: Investor presentation - Filings
- 16 days ago - ImmuCell Transcript: AGM 2026 - Transcripts
- 6 weeks ago - ImmuCell Earnings Call Transcript: Q1 2026 - Transcripts
- 6 weeks ago - ImmuCell Quarterly report: Q1 2026 - Filings
- 6 weeks ago - ImmuCell Earnings release: Q1 2026 - Filings
- 6 weeks ago - ImmuCell Slides: Q1 2026 - Filings
- 6 weeks ago - ImmuCell Slides: Investor presentation - Filings
- 6 weeks ago - ImmuCell Announces Unaudited Financial Results for the Quarter Ended March 31, 2026 - GlobeNewsWire